Publications by authors named "Hanene Attia"

Article Synopsis
  • HIF-1α is an important protein that helps control how our immune system and cells use oxygen, especially during infections.
  • The study looked at how HIF-1α levels change in human immune cells (macrophages) when infected with different types of Leishmania major parasites.
  • It found that less harmful (hypo-virulent) parasites made HIF-1α levels go up, while more harmful (hyper-virulent) ones lowered HIF-1α levels, which could affect how severe the disease becomes.
View Article and Find Full Text PDF

In human cutaneous leishmaniasis (HCL) caused by () , the cutaneous lesions heal spontaneously and induce a Th1-type immunity that confers solid protection against reinfection. The same holds true for the experimental leishmaniasis induced by in C57BL/6 mice where residual parasites persist after spontaneous clinical cure and induce sustainable memory immune responses and resistance to reinfection. Whether residual parasites also persist in scars of cured HCL caused by is still unknown.

View Article and Find Full Text PDF

The clinical expression of zoonotic cutaneous leishmaniasis (ZCL) caused by () parasites has a broad spectrum ranging from asymptomatic infection to self-limited cutaneous sores or severe disease. In concert with the host immune responses, the vector variability and the number of bites, genetic variation between isolates might impact on the clinical output of the disease. We investigated herein the intra-specific variability of field isolates independently of host or vector factors and then tried to correlate parasite variability to ZCL severity in corresponding patients.

View Article and Find Full Text PDF

Zoonotic cutaneous leishmaniasis caused by Leishmania (L.) major parasites affects urban and suburban areas in the center and south of Tunisia where the disease is endemo-epidemic. Several cases were reported in human patients for which infection due to L.

View Article and Find Full Text PDF
Article Synopsis
  • Synthesized lipophilic tyrosyl ester derivatives showed effectiveness against Leishmania species in lab tests, prompting further study of their effects in living organisms.
  • In an experiment with infected mice, only the compound TyC10 demonstrated significant anti-leishmanial activity, reducing both lesion size and parasite load.
  • TyC10 treatment also altered immune responses by shifting the balance of certain cytokines, suggesting its potential as a promising drug candidate for treating cutaneous leishmaniasis.
View Article and Find Full Text PDF

Tunisia is endemic for zoonotic cutaneous leishmaniasis (ZCL), a parasitic disease caused by Leishmania (L.) major. ZCL displays a wide clinical polymorphism, with severe forms present more frequently in emerging foci where naive populations are dominant.

View Article and Find Full Text PDF

Zoonotic cutaneous leishmaniasis (ZCL) caused by Leishmania (L.) major parasites represents a major health problem with a large spectrum of clinical manifestations. Psammomys (P.

View Article and Find Full Text PDF

Background: Leishmania (L.) are intracellular protozoan parasites able to survive and replicate in the hostile phagolysosomal environment of infected macrophages. They cause leishmaniasis, a heterogeneous group of worldwide-distributed affections, representing a paradigm of neglected diseases that are mainly embedded in impoverished populations.

View Article and Find Full Text PDF